FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merkel Cell Carcinoma
Related studies linked through entity extraction aliases.
Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
- Status
- COMPLETED
- Phase
- PHASE3
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
DOTATOC PET/CT for Imaging NET Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study
- Status
- COMPLETED
- Phase
- NA
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
T-VEC in Non-melanoma Skin Cancer
- Status
- COMPLETED
- Phase
- PHASE1
REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
- Status
- TERMINATED
- Phase
- N/A
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
French National Database of Rare Dermatological Cancers
- Status
- RECRUITING
- Phase
- N/A
QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2